Cannabinoids for Pain Management: What is their Role?

Cannabinoids for Pain Management: What is their Role?

Saved in:

Bibliographic Details
Main Authors:	Alexander J Clark, Mary E Lynch
Format:	Article
Language:	English
Published:	Wiley 2005-01-01
Series:	Pain Research and Management
Online Access:	http://dx.doi.org/10.1155/2005/978489
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
by: AJ Clark, et al.
Published: (2005-01-01)

Proceedings of the Inaugural Meeting of the Canadian Consortium for the Investigation of Cannabinoids
by: ME Lynch, et al.
Published: (2001-01-01)

Preclinical Science Regarding Cannabinoids as Analgesics: An Overview
by: ME Lynch
Published: (2005-01-01)

A Triage Approach to Managing a Two Year Wait-List in a Chronic Pain Program
by: Alexander J Clark, et al.
Published: (2005-01-01)

Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review
by: Islam Shehata, et al.
Published: (2022-10-01)

Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials
by: Mark Ware, et al.
Published: (2005-01-01)

Catastrophizing, Functional Disability and Pain Reports in Adults with Chronic Low Back Pain
by: Theresa L Vienneau, et al.
Published: (1999-01-01)

Cannabinoid Hyperemesis
by: Stephen Sullivan
Published: (2010-01-01)

Update on the Role of Cannabinoid Receptors after Ischemic Stroke
by: Luciano S. A. Capettini, et al.
Published: (2012-01-01)

The Need for a Canadian Pain Strategy
by: Mary E Lynch
Published: (2011-01-01)

Neuroprotective Actions of Cannabinoids in the Bovine Isolated Retina: Role of Hydrogen Sulfide
by: Leah Bush, et al.
Published: (2025-01-01)

Synergistic action between a synthetic cannabinoid compound and tramadol in neuropathic pain rats
by: Quiñonez-Bastidas Geovanna Nallely, et al.
Published: (2022-12-01)

Do We Care about People with Chronic Pain?
by: Mary E Lynch
Published: (2008-01-01)

Detection of Cannabinoid Receptor Expression by Endometriotic Lesions in Women with Endometriosis as an Alternative to Opioid-Based Pain Medication
by: Sarah Allam, et al.
Published: (2022-01-01)

Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01)

Chronic Pain in Canada: Have We Improved Our Management of Chronic Noncancer Pain?
by: Aline Boulanger, et al.
Published: (2007-01-01)

Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
by: Wen S. Sheng, et al.
Published: (2019-01-01)

Chronic Pain in Canada - Prevalence, Treatment, Impact and the Role of Opioid Analgesia
by: Dwight E Moulin, et al.
Published: (2002-01-01)

The Pharmacotherapy of Chronic Pain: A Review
by: Mary E Lynch, et al.
Published: (2006-01-01)

Cannabinoids in the Brain: New Vistas on an Old Dilemma
by: Maurice Ptito, et al.
Published: (2016-01-01)

Placental Cannabinoid Receptor Expression in Preterm Birth
by: Stepan Feduniw, et al.
Published: (2024-01-01)

Cannabinoids: A New Group of Agonists of PPARs
by: Yan Sun, et al.
Published: (2007-01-01)

The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
by: Jose Orsini, et al.
Published: (2015-01-01)

Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use
by: Julia Hermes-Laufer, et al.
Published: (2016-01-01)

Research Funding for Pain in Canada
by: Mary E Lynch, et al.
Published: (2009-01-01)

First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
by: Aaron J. Roberto, et al.
Published: (2016-01-01)

Safety Issues Concerning the Medical Use of Cannabis and Cannabinoids
by: Mark A Ware, et al.
Published: (2005-01-01)

Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome
by: Han Y. Yin, et al.
Published: (2020-01-01)

Brugada Phenocopy Type 1 Secondary to Synthetic Cannabinoids
by: Mohammad Amro, et al.
Published: (2020-01-01)

A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
by: Osamah Hasan, et al.
Published: (2019-01-01)

The Role of Controlled Breathing in Pain Management
by: Maria Wydro, et al.
Published: (2025-02-01)

Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection
by: Michaela Dvorakova, et al.
Published: (2025-02-01)

Editorial: Cognitive stimulants: from caffeine to cannabinoids - current and future perspectives
by: Daniel Moreira-Silva, et al.
Published: (2025-01-01)

Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids
by: Aiyu Zhao, et al.
Published: (2015-01-01)

What is Phase II NPDES?
by: Mark W. Clark
Published: (2004-04-01)

What is Phase II NPDES?
by: Mark W. Clark
Published: (2004-04-01)

Pharmacological Management of Chronic Neuropathic Pain – Consensus Statement and Guidelines from the Canadian Pain Society
by: DE Moulin, et al.
Published: (2007-01-01)

Therapeutic potential of cannabinoids in neurological conditions: a systematic review of clinical trials
by: Alqassem Y. Hakami, et al.
Published: (2025-02-01)

Engineering a promiscuous prenyltransferase for selective biosynthesis of an undescribed bioactive cannabinoid analog
by: Qin Yan, et al.
Published: (2025-02-01)

Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid Withdrawal
by: Ahmet Bulent Yazici, et al.
Published: (2017-01-01)